Immix Biopharma prices 4.2M-share IPO at $5

designer491/iStock via Getty Images

• Immix Biopharma (NASDAQ:IMMX) has priced its IPO of 4.2M shares of common stock at $5.00/share, for gross proceeds of $21M.
• Underwriters' over-allotment is an additional 630K shares.
• Nasdaq trading commences on December 16, 2021.
• Closing